×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Edgewise Therapeutics Inc. (EWTX) NASDAQ

$17.80 (0.16) (-0.89%)

Market Cap: $1.67B

As of 03/28/24 02:09 PM EDT. Market open.

(EWTX)

Edgewise Therapeutics Inc. (EWTX)
NASDAQ

$17.80
(0.16) (-0.89%)

Market Cap: $1.67B

As of 03/28/24 02:09 PM EDT. Market open.

Add to Portfolio

edgewise therapeutics is a biotechnology company focused on developing novel therapies for diseases involving skeletal muscle. the company is headquartered in boulder, co and received its series a financing from ... read more

edgewise therapeutics is a biotechnology company focused on developing novel therapies for diseases involving skeletal muscle. the company is headquartered in boulder, co and received its series a financing from orbimed. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Medicinal and Botanical Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Medicinal and Botanical Manufacturing
Full Time Employees
79
Address
.
PRICE CHART FOR EDGEWISE THERAPEUTICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$17.97
Previous Close
$17.96
Days Range
$17.33 - $18.10
52 week range
$5.12 - $20.69
Volume
139,156
Avg. Volume (30 days)
924,905
Market Cap
$1.67B
Dividend Yield
-
P/E
-
Shares Outstanding
93,110,623
Open
$17.97
Previous Close
$17.96
Days Range
$17.33 - $18.10
52 week range
$5.12 - $20.69
Volume
139,156
Avg. Volume (30 days)
924,905
Market Cap
$1.67B
Dividend Yield
-
P/E
-
Shares Outstanding
93,110,623
FINANCIAL STATEMENTS FOR EDGEWISE THERAPEUTICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR EDGEWISE THERAPEUTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
MOORE JOHN RGeneral CounselFeb 07, 2024 Option Exercise$1.9317,99334,72617,993Feb 09, 2024, 05:43 PM
MOORE JOHN RGeneral CounselFeb 09, 2024 Option Exercise$1.938,02915,4968,029Feb 09, 2024, 05:43 PM
MOORE JOHN RGeneral CounselFeb 08, 2024 Option Exercise$1.933,8137,3593,813Feb 09, 2024, 05:43 PM
MOORE JOHN RGeneral CounselFeb 07, 2024 Sale$20.0017,993359,8640Feb 09, 2024, 05:43 PM
MOORE JOHN RGeneral CounselFeb 09, 2024 Sale$20.018,029160,6570Feb 09, 2024, 05:43 PM
MOORE JOHN RGeneral CounselFeb 08, 2024 Sale$20.013,81376,2850Feb 09, 2024, 05:43 PM
Derakhshan BehradChief Business OfficerFeb 07, 2024 Option Exercise$1.936001,1587,620Feb 09, 2024, 05:42 PM
Derakhshan BehradChief Business OfficerFeb 09, 2024 Option Exercise$1.934,8009,26411,820Feb 09, 2024, 05:42 PM
Derakhshan BehradChief Business OfficerFeb 08, 2024 Option Exercise$1.934,6008,87811,620Feb 09, 2024, 05:42 PM
Derakhshan BehradChief Business OfficerFeb 07, 2024 Sale$20.0060012,0007,020Feb 09, 2024, 05:42 PM
Derakhshan BehradChief Business OfficerFeb 09, 2024 Sale$20.044,80096,2097,020Feb 09, 2024, 05:42 PM
Derakhshan BehradChief Business OfficerFeb 08, 2024 Sale$20.014,60092,0497,020Feb 09, 2024, 05:42 PM
Carruthers R MichaelChief Financial OfficerJan 23, 2024 Option Exercise$1.9390,000173,700119,024Jan 25, 2024, 04:46 PM
Carruthers R MichaelChief Financial OfficerJan 23, 2024 Sale$15.7890,0001,419,75929,024Jan 25, 2024, 04:46 PM
Thompson Peter A.DirectorJan 23, 2024 Buy$11.00454,5454,999,99514,436,497Jan 25, 2024, 04:32 PM
ORBIMED ADVISORS LLCDirectorJan 23, 2024 Buy$11.00454,5454,999,99514,436,497Jan 25, 2024, 04:28 PM
Fox Jonathan CDirectorDec 26, 2023 Buy$9.3010,857100,95810,857Dec 28, 2023, 04:39 PM
MOORE JOHN RGeneral CounselDec 27, 2023 Sale$10.508,49789,2190Dec 28, 2023, 04:39 PM
Russell Alan JChief Scientific OfficerDec 26, 2023 Sale$9.33172,5851,610,0973,606Dec 28, 2023, 04:38 PM
Carruthers R MichaelChief Financial OfficerJun 22, 2023 Option Exercise$0.7110,0007,10029,024Jun 26, 2023, 04:28 PM
Derakhshan BehradChief Business OfficerMay 02, 2023 Sale$8.901,74715,5577,020May 03, 2023, 06:26 PM
MOORE JOHN RGeneral CounselMay 02, 2023 Sale$8.901,89716,8936,565May 03, 2023, 06:26 PM
Carruthers R MichaelChief Financial OfficerMay 02, 2023 Sale$8.901,33611,89716,126May 03, 2023, 06:26 PM
Russell Alan JChief Scientific OfficerMay 02, 2023 Sale$8.901,60214,266176,191May 03, 2023, 06:26 PM
Donovan Joanne M.CMOMay 02, 2023 Sale$8.903,25428,9779,960May 03, 2023, 06:25 PM
KOCH KEVINPresident and CEOMay 02, 2023 Sale$8.903,20328,5227,213May 03, 2023, 06:25 PM
MOORE JOHN RGeneral CounselOct 03, 2022 Option Exercise$1.934,7309,1297,730Oct 05, 2022, 04:42 PM
MOORE JOHN RGeneral CounselOct 03, 2022 Sale$9.764,73046,1553,000Oct 05, 2022, 04:42 PM
Thompson Peter A.DirectorSep 16, 2022 Buy$10.32484,4964,999,99913,981,952Sep 16, 2022, 04:34 PM
ORBIMED ADVISORS LLCDirectorSep 16, 2022 Buy$10.32484,4964,999,99913,981,952Sep 16, 2022, 04:31 PM
Novo Holdings A/S10% OwnerSep 14, 2022 Buy$10.32484,4964,999,9996,071,703Sep 16, 2022, 02:35 PM
MOORE JOHN RGeneral CounselSep 06, 2022 Option Exercise$1.934,7309,1297,730Sep 08, 2022, 04:16 PM
MOORE JOHN RGeneral CounselSep 06, 2022 Sale$10.914,73051,5985,351Sep 08, 2022, 04:16 PM
MOORE JOHN RGeneral CounselAug 03, 2022 Option Exercise$1.349,23212,32512,232Aug 05, 2022, 04:12 PM
MOORE JOHN RGeneral CounselAug 03, 2022 Sale$9.319,23285,9213,000Aug 05, 2022, 04:12 PM
MOORE JOHN RGeneral CounselJul 06, 2022 Option Exercise$1.931,0462,0194,046Jul 07, 2022, 04:23 PM
MOORE JOHN RGeneral CounselJul 05, 2022 Option Exercise$1.268,18610,30711,186Jul 07, 2022, 04:23 PM
MOORE JOHN RGeneral CounselJul 05, 2022 Sale$8.358,18668,3293,000Jul 07, 2022, 04:23 PM
MOORE JOHN RGeneral CounselJul 06, 2022 Sale$8.541,0468,9283,000Jul 07, 2022, 04:23 PM
MOORE JOHN RGeneral CounselJun 16, 2022 Option Exercise$1.9314,72228,41317,722Jun 21, 2022, 06:50 PM
MOORE JOHN RGeneral CounselJun 21, 2022 Option Exercise$1.4031,07843,50134,078Jun 21, 2022, 06:50 PM
MOORE JOHN RGeneral CounselJun 17, 2022 Option Exercise$1.9322,12742,70525,127Jun 21, 2022, 06:50 PM
MOORE JOHN RGeneral CounselJun 16, 2022 Sale$6.1714,72290,8053,000Jun 21, 2022, 06:50 PM
MOORE JOHN RGeneral CounselJun 21, 2022 Sale$7.2931,078226,6953,000Jun 21, 2022, 06:50 PM
MOORE JOHN RGeneral CounselJun 17, 2022 Sale$6.6222,127146,4343,000Jun 21, 2022, 06:50 PM
MOORE JOHN RGeneral CounselJun 13, 2022 Option Exercise$0.714,0932,9067,093Jun 15, 2022, 06:39 PM
MOORE JOHN RGeneral CounselJun 15, 2022 Option Exercise$0.7518,66013,96221,660Jun 15, 2022, 06:39 PM
MOORE JOHN RGeneral CounselJun 14, 2022 Option Exercise$0.713,6282,5766,628Jun 15, 2022, 06:39 PM
MOORE JOHN RGeneral CounselJun 13, 2022 Sale$6.014,09324,5823,000Jun 15, 2022, 06:39 PM
MOORE JOHN RGeneral CounselJun 15, 2022 Sale$6.1118,660114,02021,075Jun 15, 2022, 06:39 PM
MOORE JOHN RGeneral CounselJun 14, 2022 Sale$6.023,62821,8553,000Jun 15, 2022, 06:39 PM
MOORE JOHN RGeneral CounselJun 08, 2022 Option Exercise$0.7112,5668,92215,566Jun 10, 2022, 06:34 PM
MOORE JOHN RGeneral CounselJun 10, 2022 Option Exercise$0.717,1255,05910,125Jun 10, 2022, 06:34 PM
MOORE JOHN RGeneral CounselJun 09, 2022 Option Exercise$0.717,6155,40710,615Jun 10, 2022, 06:34 PM
MOORE JOHN RGeneral CounselJun 10, 2022 Sale$6.057,12543,1203,000Jun 10, 2022, 06:34 PM
MOORE JOHN RGeneral CounselJun 09, 2022 Sale$6.497,61549,3973,000Jun 10, 2022, 06:34 PM
MOORE JOHN RGeneral CounselJun 08, 2022 Sale$6.6312,56683,3623,000Jun 10, 2022, 06:34 PM
MOORE JOHN RGeneral CounselJun 03, 2022 Option Exercise$1.9315,23029,39418,230Jun 07, 2022, 07:03 PM
MOORE JOHN RGeneral CounselJun 07, 2022 Option Exercise$0.7818,12314,05420,150Jun 07, 2022, 07:03 PM
MOORE JOHN RGeneral CounselJun 06, 2022 Option Exercise$1.9313,93426,89316,934Jun 07, 2022, 07:03 PM
MOORE JOHN RGeneral CounselJun 07, 2022 Sale$6.6118,123119,7023,000Jun 07, 2022, 07:03 PM
MOORE JOHN RGeneral CounselJun 06, 2022 Sale$6.0313,93484,0853,000Jun 07, 2022, 07:03 PM
MOORE JOHN RGeneral CounselJun 03, 2022 Sale$6.0515,23092,1983,000Jun 07, 2022, 07:03 PM
Carruthers R MichaelChief Financial OfficerMay 23, 2022 Option Exercise$0.719,0006,39012,000May 25, 2022, 06:11 PM
ORBIMED ADVISORS LLCDirectorMay 18, 2022 Buy$7.21138,000994,98013,497,456May 20, 2022, 04:38 PM
Thompson Peter A.DirectorMay 18, 2022 Buy$7.21138,000994,98013,497,456May 20, 2022, 04:32 PM
MOORE JOHN RGeneral CounselMay 16, 2022 Sale$7.4210,80080,1463,000May 18, 2022, 05:15 PM
MOORE JOHN RGeneral CounselJan 21, 2022 Option Exercise$0.715,4003,83412,362Jan 25, 2022, 06:50 PM
MOORE JOHN RGeneral CounselDec 28, 2021 Option Exercise$0.715,4003,8346,962Dec 30, 2021, 05:51 PM
Russell Alan JChief Scientific OfficerNov 30, 2021 Option Exercise$0.22172,58537,815172,585Dec 01, 2021, 06:20 PM
Russell Alan JChief Scientific OfficerNov 15, 2021 Sale$19.114799,15538Nov 17, 2021, 06:05 PM
Russell Alan JChief Scientific OfficerNov 12, 2021 Sale$19.518,562167,074479Nov 12, 2021, 05:24 PM
Russell Alan JChief Scientific OfficerNov 11, 2021 Sale$19.9319,276384,23812,722Nov 12, 2021, 05:24 PM
Russell Alan JChief Scientific OfficerNov 10, 2021 Sale$19.7312,326243,17028,897Nov 12, 2021, 05:24 PM
Russell Alan JChief Scientific OfficerNov 09, 2021 Sale$20.0929,576594,30653,355Nov 12, 2021, 05:24 PM
Russell Alan JChief Scientific OfficerNov 08, 2021 Sale$20.169,017181,82470,219Nov 08, 2021, 07:11 PM
Russell Alan JChief Scientific OfficerNov 05, 2021 Sale$19.6213,042255,90792,272Nov 08, 2021, 07:11 PM
Russell Alan JChief Scientific OfficerNov 04, 2021 Sale$19.767,392146,09292,278Nov 08, 2021, 07:11 PM
Russell Alan JChief Scientific OfficerNov 03, 2021 Sale$18.1826,184476,096105,032Nov 03, 2021, 07:00 PM
Russell Alan JChief Scientific OfficerNov 02, 2021 Sale$17.4317,519305,360125,854Nov 03, 2021, 07:00 PM
Russell Alan JChief Scientific OfficerNov 01, 2021 Sale$18.024698,454143,373Nov 03, 2021, 07:00 PM
Russell Alan JChief Scientific OfficerOct 15, 2021 Sale$18.121,43325,966143,968Oct 18, 2021, 07:48 PM
Russell Alan JChief Scientific OfficerOct 14, 2021 Sale$18.185,749104,517145,275Oct 18, 2021, 07:48 PM
Russell Alan JChief Scientific OfficerOct 11, 2021 Sale$18.021,27022,885151,024Oct 13, 2021, 06:51 PM
Russell Alan JChief Scientific OfficerOct 08, 2021 Sale$18.155,902107,121152,294Oct 08, 2021, 06:00 PM
Russell Alan JChief Scientific OfficerOct 07, 2021 Sale$18.5613,018241,614158,196Oct 08, 2021, 06:00 PM
Russell Alan JChief Scientific OfficerOct 06, 2021 Sale$18.032,10838,007171,214Oct 08, 2021, 06:00 PM
Russell Alan JChief Scientific OfficerOct 04, 2021 Sale$18.001001,800178,726Oct 05, 2021, 06:33 PM
Russell Alan JChief Scientific OfficerOct 01, 2021 Sale$18.002744,932178,826Oct 05, 2021, 06:33 PM
Russell Alan JChief Scientific OfficerOct 05, 2021 Sale$18.265,40498,677173,322Oct 05, 2021, 06:33 PM
Russell Alan JChief Scientific OfficerSep 29, 2021 Sale$16.8611,844199,730179,718Sep 30, 2021, 07:16 PM
Russell Alan JChief Scientific OfficerSep 28, 2021 Sale$17.3014,610252,753190,944Sep 30, 2021, 07:16 PM
Russell Alan JChief Scientific OfficerSep 23, 2021 Sale$18.5426,835497,632242,337Sep 27, 2021, 07:32 PM
Russell Alan JChief Scientific OfficerSep 27, 2021 Sale$17.9811,611208,774205,571Sep 27, 2021, 07:32 PM
Russell Alan JChief Scientific OfficerSep 24, 2021 Sale$18.1620,100365,016217,165Sep 27, 2021, 07:32 PM
ROOT JONATHAN DDirectorMar 30, 2021 Buy$16.0015,625250,00015,625Mar 31, 2021, 07:12 PM
Thompson Peter A.DirectorMar 30, 2021 Buy$16.00359,3755,750,00013,359,456Mar 31, 2021, 07:11 PM
ORBIMED ADVISORS LLCDirectorMar 30, 2021 Buy$16.00359,3755,750,00013,359,456Mar 31, 2021, 07:10 PM
Novo Holdings A/S10% OwnerMar 30, 2021 Buy$16.00625,00010,000,0005,587,207Mar 31, 2021, 04:36 PM
Flynn James E10% OwnerMar 30, 2021 Buy$16.00625,00010,000,0003,933,137Mar 30, 2021, 03:42 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
MOORE JOHN RGeneral Counsel02/07/202434,726
MOORE JOHN RGeneral Counsel02/09/202415,496
MOORE JOHN RGeneral Counsel02/08/20247,359
MOORE JOHN RGeneral Counsel02/07/2024359,864
MOORE JOHN RGeneral Counsel02/09/2024160,657
MOORE JOHN RGeneral Counsel02/08/202476,285
Derakhshan BehradChief Business Officer02/07/20241,158
Derakhshan BehradChief Business Officer02/09/20249,264
Derakhshan BehradChief Business Officer02/08/20248,878
Derakhshan BehradChief Business Officer02/07/202412,000
Derakhshan BehradChief Business Officer02/09/202496,209
Derakhshan BehradChief Business Officer02/08/202492,049
Carruthers R MichaelChief Financial Officer01/23/2024173,700
Carruthers R MichaelChief Financial Officer01/23/20241,419,759
Thompson Peter A.Director01/23/20244,999,995
ORBIMED ADVISORS LLCDirector01/23/20244,999,995
Fox Jonathan CDirector12/26/2023100,958
MOORE JOHN RGeneral Counsel12/27/202389,219
Russell Alan JChief Scientific Officer12/26/20231,610,097
Carruthers R MichaelChief Financial Officer06/22/20237,100
Derakhshan BehradChief Business Officer05/02/202315,557
MOORE JOHN RGeneral Counsel05/02/202316,893
Carruthers R MichaelChief Financial Officer05/02/202311,897
Russell Alan JChief Scientific Officer05/02/202314,266
Donovan Joanne M.CMO05/02/202328,977
KOCH KEVINPresident and CEO05/02/202328,522
MOORE JOHN RGeneral Counsel10/03/20229,129
MOORE JOHN RGeneral Counsel10/03/202246,155
Thompson Peter A.Director09/16/20224,999,999
ORBIMED ADVISORS LLCDirector09/16/20224,999,999
Novo Holdings A/S10% Owner09/14/20224,999,999
MOORE JOHN RGeneral Counsel09/06/20229,129
MOORE JOHN RGeneral Counsel09/06/202251,598
MOORE JOHN RGeneral Counsel08/03/202212,325
MOORE JOHN RGeneral Counsel08/03/202285,921
MOORE JOHN RGeneral Counsel07/06/20222,019
MOORE JOHN RGeneral Counsel07/05/202210,307
MOORE JOHN RGeneral Counsel07/05/202268,329
MOORE JOHN RGeneral Counsel07/06/20228,928
MOORE JOHN RGeneral Counsel06/16/202228,413
MOORE JOHN RGeneral Counsel06/21/202243,501
MOORE JOHN RGeneral Counsel06/17/202242,705
MOORE JOHN RGeneral Counsel06/16/202290,805
MOORE JOHN RGeneral Counsel06/21/2022226,695
MOORE JOHN RGeneral Counsel06/17/2022146,434
MOORE JOHN RGeneral Counsel06/13/20222,906
MOORE JOHN RGeneral Counsel06/15/202213,962
MOORE JOHN RGeneral Counsel06/14/20222,576
MOORE JOHN RGeneral Counsel06/13/202224,582
MOORE JOHN RGeneral Counsel06/15/2022114,020
MOORE JOHN RGeneral Counsel06/14/202221,855
MOORE JOHN RGeneral Counsel06/08/20228,922
MOORE JOHN RGeneral Counsel06/10/20225,059
MOORE JOHN RGeneral Counsel06/09/20225,407
MOORE JOHN RGeneral Counsel06/10/202243,120
MOORE JOHN RGeneral Counsel06/09/202249,397
MOORE JOHN RGeneral Counsel06/08/202283,362
MOORE JOHN RGeneral Counsel06/03/202229,394
MOORE JOHN RGeneral Counsel06/07/202214,054
MOORE JOHN RGeneral Counsel06/06/202226,893
MOORE JOHN RGeneral Counsel06/07/2022119,702
MOORE JOHN RGeneral Counsel06/06/202284,085
MOORE JOHN RGeneral Counsel06/03/202292,198
Carruthers R MichaelChief Financial Officer05/23/20226,390
ORBIMED ADVISORS LLCDirector05/18/2022994,980
Thompson Peter A.Director05/18/2022994,980
MOORE JOHN RGeneral Counsel05/16/202280,146
MOORE JOHN RGeneral Counsel01/21/20223,834
MOORE JOHN RGeneral Counsel12/28/20213,834
Russell Alan JChief Scientific Officer11/30/202137,815
Russell Alan JChief Scientific Officer11/15/20219,155
Russell Alan JChief Scientific Officer11/12/2021167,074
Russell Alan JChief Scientific Officer11/11/2021384,238
Russell Alan JChief Scientific Officer11/10/2021243,170
Russell Alan JChief Scientific Officer11/09/2021594,306
Russell Alan JChief Scientific Officer11/08/2021181,824
Russell Alan JChief Scientific Officer11/05/2021255,907
Russell Alan JChief Scientific Officer11/04/2021146,092
Russell Alan JChief Scientific Officer11/03/2021476,096
Russell Alan JChief Scientific Officer11/02/2021305,360
Russell Alan JChief Scientific Officer11/01/20218,454
Russell Alan JChief Scientific Officer10/15/202125,966
Russell Alan JChief Scientific Officer10/14/2021104,517
Russell Alan JChief Scientific Officer10/11/202122,885
Russell Alan JChief Scientific Officer10/08/2021107,121
Russell Alan JChief Scientific Officer10/07/2021241,614
Russell Alan JChief Scientific Officer10/06/202138,007
Russell Alan JChief Scientific Officer10/04/20211,800
Russell Alan JChief Scientific Officer10/01/20214,932
Russell Alan JChief Scientific Officer10/05/202198,677
Russell Alan JChief Scientific Officer09/29/2021199,730
Russell Alan JChief Scientific Officer09/28/2021252,753
Russell Alan JChief Scientific Officer09/23/2021497,632
Russell Alan JChief Scientific Officer09/27/2021208,774
Russell Alan JChief Scientific Officer09/24/2021365,016
ROOT JONATHAN DDirector03/30/2021250,000
Thompson Peter A.Director03/30/20215,750,000
ORBIMED ADVISORS LLCDirector03/30/20215,750,000
Novo Holdings A/S10% Owner03/30/202110,000,000
Flynn James E10% Owner03/30/202110,000,000
Load More Insider Transactions
FUNDS WITH A POSITION IN EDGEWISE THERAPEUTICS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
ORBIMED ADVISORS LLC14,756,0963.24%1.30%Other
VIKING GLOBAL INVESTORS LP6,159,1460.25%No changeGrowth At A Reasonable Price
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)3,933,1370.79%No changeOther
BlackRock Inc.3,505,1990.00159%5.99%Other
BAKER BROS. ADVISORS LP3,112,7860.39%196.54%Other
GEODE CAPITAL MANAGEMENT, LLC947,0460.00108%6.2%Other
DRIEHAUS CAPITAL MANAGEMENT LLC395,0690.05%NewGrowth
CANDRIAM S.C.A.308,0000.02%3.36%Other
RENAISSANCE TECHNOLOGIES LLC64,7000.0011%-57.15%Other
UBS OCONNOR LLC114,6850.09%-18%Value
ALPS ADVISORS INC43,2260.00372%-7.78%Other
D. E. SHAW & CO., INC.31,9500.00031%NewOther
CHANGE IN SHARES OUTSTANDING FOR EDGEWISE THERAPEUTICS INC
STOCK BUYBACKS FOR EDGEWISE THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
2.09%
1Q
12/31/2023
06/30/2023
2.22%
2Q
12/31/2023
03/31/2023
2.40%
3Q
12/31/2023
12/31/2022
2.29%
4Q
12/31/2023
09/30/2022
24.96%
5Q
12/31/2023
06/30/2022
30.56%
6Q
12/31/2023
03/31/2022
30.76%
7Q
12/31/2023
12/31/2021
72.64%
8Q
12/31/2023
09/30/2021
31.51%
9Q
12/31/2023
06/30/2021
31.52%
10Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
2.09%
1Q
06/30/2023
2.22%
2Q
03/31/2023
2.40%
3Q
12/31/2022
2.29%
4Q
09/30/2022
24.96%
5Q
06/30/2022
30.56%
6Q
03/31/2022
30.76%
7Q
12/31/2021
72.64%
8Q
09/30/2021
31.51%
9Q
06/30/2021
31.52%
10Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR EDGEWISE THERAPEUTICS INC
LOADING...